Form EFFECT Acurx Pharmaceuticals,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 29, 2025 4:01 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Seeker Price Prediction: SKR Jumps 29% as Remittix’s Crypto-to-Bank Model Draws Early-Move Buyers
- Cronos Price Prediction: CRO Extends Its Weekly Recovery as Remittix Builds a Global Crypto-to-Bank Payments Network
- There's Only One Champion, but Countless Ways to Shine: OMODA and Young People Worldwide – "Play Your Own Round"
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share